Journal of Comparative Effectiveness Research

Article	Citations
Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more	127
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy	46
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis	41
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance database	38
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis	36
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea	28
Journal of Comparative Effectiveness Research : 2022 year in review	25
An observational cohort study of pelvic floor photobiomodulation for treatment of chronic pelvic pain	24
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis	24
Engaging veterans in the research process: a practical guide	22
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis	22
Corrigendum	21
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies	21
Discharges against medical advice and 30-day healthcare costs: an analysis of commercially insured adults	19
Cost–effectiveness analysis of a resource-intensive approach versus minimally invasive strategy for high-risk transcatheter aortic valve replacement patients	19
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study	19
Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims	18
Impact of clinical research coordinators on research output in orthopedic surgery	18
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis	18
Ravulizumab in adults and children with atypical hemolytic uremic syndrome: a plain language summary of three studies	17
The cost–effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA	17
Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer	15
Healthcare utilization and costs following molecular diagnostic testing among patients with vaginitis	15
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience	15
Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis	14

Clinical assessment of the potential use of a novel single-dose prefilled injection device for the administration of Acthar Gel in children: a narrative review	14
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity	13
Letter in reply	13
EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?	12
Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases	12
Cost–effectiveness analysis of prolonged-release fampridine to treat walking disability of multiple sclerosis in China	12
Corrigendum	12
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab	11
Cost–effectiveness of lung cancer screening with volume computed tomography in Portugal	11
Validity of comorbidity adjustment scores in estimating in-hospital mortality in individual subgroups of race/ethnicity	11
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis	11
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer	11
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients	11
R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 3	11
Healthcare costs and resource utilization of patients with chronic post-traumatic stress disorder: a retrospective US claims analysis of commercially insured patients	10
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema	10
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada	10
Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations	10
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer	9
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma	9
Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors	9
Preferences, satisfaction and decision-making processes in osteoporosis treatment: a systematic review of the literature	9
Characterization of medical device randomized controlled trials with adaptive designs	9
Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib	9
Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies	9
To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiative	9
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol	9
Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practic	8
Comparison of intravenous versus topical tranexamic acid in primary total hip arthroplasty: a systematic review and meta-analysis of ten randomized trials	8
Evidence-based public policy making for medicines across countries: findings and implications for the future	8
How the use of standardized protocols may paradoxically worsen disparities for safety-net hospitals	8
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema	8
Diversity in clinical trial inclusion for peripheral artery disease lower extremity endovascular interventions: a systematic review protocol	8
The triple win – implementation science benefits patients, healthcare systems and industry alike	8
Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder	8
Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes	8
Comparison of Enterprise stent 2 with 1 in assisting coiling of ruptured aneurysms: a real-world study	8
Impact analysis of expanding narrow-spectrum antibiotic use for children with ear, sinus and throat infections	8
Impact of COVID-19 on chronic pain structures: data from French national survey	7
COVID-19 clinical trials: who is likely to participate and why?	7
Corrigendum	7
Healthcare resource utilization and costs in pediatric pulmonary arterial hypertension in a third-level hospital in Mexico	7
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care	7
The effects of Pilates on pain, functionality, quality of life, flexibility and endurance in lumbar disc herniation	7
Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome	7
Access in all areas? A round up of developments in market access and health technology assessment: part 1	7
Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis	7
Economic analysis of the use of video laryngoscopy versus direct laryngoscopy in the surgical setting	7
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10	7
Single-arm oncology trials and the nature of external controls arms	7

Navigating adalimumab biosimilars: an expert opinion	6
The health-related quality of life of patients with a benign gynecological condition: a 2-year follow-up	6
Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization	6
Expanding the learning health system model to be health literate	6
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design	6
The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives	6
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary	6
An impact evaluation of an education bundle for patients at risk of developing venous thromboembolism	6
Does off-hours endoscopic hemostasis affect outcomes of nonvariceal upper gastrointestinal bleeding?	6
A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications	6
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations	6
Cost–effectiveness of ensartinib for patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer in China	6
An economic evaluation of teledermatology care delivery for chronic skin diseases	6
Use of transportability methods for real-world evidence generation: a review of current applications	6
Cost–effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes	6
Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk	6
Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma	6
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers	6
Assessing the change in disease severity based on depressive symptoms in real-world psoriasis patients	6
An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD	6
Treatment goals for rheumatoid arthritis: patient engagement and goal collection	6
Application of quantitative bias analysis for unmeasured confounding in cost–effectiveness modelling	5
In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database	5
Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here	5
R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2	5
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib	5
A value-based budget impact model for dronedarone compared with other rhythm control strategies	5
Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data	5
Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant	5
Navigating the unknown: how to best ‘reflect’ standard of care in indications without a dedicated treatment pathway in health technology assessment submissions	5
Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses	5
Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs	5
Robotic-assisted total hip arthroplasty: an economic analysis	5
QDOT MICRO™ versus THERMOCOOL ® SMARTTOUCH™ and THERMOCOOL SMARTTOUCH ® Surround Flow in radiofrequency ablation of paroxysmal atr	5
Economic impact of reduced postoperative visits after inflatable penile prosthesis implantation	5
Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US	5
COVID-19 complications in males and females: recent developments	5
Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes	5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15	5
Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges	5
Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study	4
Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study	4
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study	4
Cost–effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma	4
Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy	4
Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis	4
An international observational study assessing conservative management in hemorrhoidal disease: results of CHORALIS (aCute HemORrhoidal disease evALuation International Study)	4
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA	4
Impact analysis of expanded access to ketamine for treatment-resistant depression	4
How pharma can amplify product value with implementation science	4
Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease	4
Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants	4
Evaluation of inpatient and emergency department healthcare resource utilization and costs pre- and post-nusinersen for the treatment of spinal muscular atrophy using United States claims	4
The need to consider market access for pharmaceutical investment decisions: a primer	4
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms	4
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data	4
Val (EU) xit: do we need an international ISPOR value flower?	4
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4	4
The effect of midodrine on lactate clearance in patients with septic shock: a pilot study	4
Respiratory and nonrespiratory COVID-19 complications in patients with obesity: recent developments	4
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis	4
Visualizing the target estimand in comparative effectiveness studies with multiple treatments	4
Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC	4
Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease	4
Efficacy of CARVYKTI in CARTITUDE-4 versus other conventional treatment regimens for lenalidomide-refractory multiple myeloma using inverse probability of treatment weighting	4
Economic burden of lives lost due to COVID-19 in California State	3
Promoting community stakeholder engagement in research on treatment for pregnant women with opioid use disorder	3
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study	3
Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis	3
A process to validate prognostic factors for unanchored matching-adjusted indirect comparison of single-arm trials in oncology: a proof-of-concept study	3
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China	3
Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study	3
The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey	3
Access to medicines in the Brazilian Unified Health System’s primary health care: assessment of a public policy	3
Meta-analysis of visual pretreatment for the prevention of emergence delirium in children undergoing ophthalmic surgery	3
Screening for diminished ovarian reserve in Portugal: a cost-saving answer to shorten the fertility journey	3
PEG hydrogel sealant versus fibrin glue in posterior fossa surgery: an economic comparison across five European countries	3
A real world cost-minimization analysis comparing the use of different endoscopic staplers in video-assisted thoracic surgery lobectomy procedures	3
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis	3
The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark	3

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19	3
Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema	3
Distinguishing cardiac catheter ablation energy modalities by applying natural language processing to electronic health records	3
Potential policy reforms to strengthen the accelerated approval pathway	3
Clinical outcomes of retrievable inferior vena cava filters for venous thromboembolic diseases	3
Cost–effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancer	3
Robot-assisted minimally invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion: a retrospective matched-control analysis for clinical and quality-of-life o	3
Novel and existing flexible survival methods for network meta-analyses	3
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis	3
Implementation of electronic patient-reported outcomes for symptom monitoring during cancer treatment: the importance of getting it right	3
Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary	3
Use of interrupted time-series analyses in evaluating health economic outcomes following implementation of multilayer water-tight wound closure in a primary total joint arthroplasty population	3
Systematic literature review of evidence in amyloid light-chain amyloidosis	3
A US national update of health condition prevalence among privately-insured autistic adults	3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18	3
DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain	3
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making	3
Factors impacting chronic disease medication adherence in the UAE: a prospective cohort study, 2021–2022	3
Sex-based differences in the outcomes of patients with lung carcinoids	3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17	3
Comparing the performance of two-stage residual inclusion methods when using physician's prescribing preference as an instrumental variable: unmeasured confounding and noncollapsibility	3
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment c	3
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes	3
Are eSports more than just sitting? A study comparing energy expenditure	3
Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation	3
Comparing the outcomes and costs of cardiac monitoring with implantable loop recorders and mobile cardiac outpatient telemetry following stroke using real-world evidence	3
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer	3
The burden of Alagille syndrome: uncovering the potential of emerging therapeutics – a comprehensive systematic literature review	3
Corrigendum	3
Why is target trial emulation not being used in health technology assessment real-world data submissions?	3
Prognostic and predictive value of microsatellite instability status among patients with colorectal cancer	3
Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study	3
Access in all areas? a round up of developments in market access and health technology assessment: part 4	3
Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review	3
Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary	3
Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study	3
A clinical decision support tool for metabolic dysfunction-associated steatohepatitis in real-world clinical settings: a mixed-method implementation research study protocol	3
Economic burden of complicated ureteral stent removal in patients with kidney stone disease in the USA	3
The effects of exercises with a Pilates ball on balance, reaction time and dual-task performance of kindergarten children	3
Matching-adjusted indirect comparison via a polynomial-based non-linear optimization method	3
Access in all areas? A roundup of developments in market access and health technology assessment: part 6	3
Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus	3
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis	3
Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals	2
Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison	2
The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries	2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5	2
A real-world, population-based study for the outcomes of patients with metastatic colorectal cancer to the liver with distant lymph node metastases treated with metastasectomy	2
Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil	2
Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver	2
Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study	2
Cost–effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain	2
Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema	2
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics	2
Effects of 12-week Pilates training program on cardiac autonomic modulation: a randomized controlled clinical trial	2
Improved estimation of overall survival and progression-free survival for state transition modeling	2
Evaluation of reporting in time-driven activity-based costing studies on cardiovascular diseases: a scoping review	2
Design and methods of a tailored approach for diabetes prevention in women with previous gestational diabetes	2
Healthcare utilization among children with early autism diagnoses, children with other developmental delays and a comparison group	2
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary	2
Flexibility in assessment of rare disease technologies via NICE's single technology appraisal route: a thematic analysis	2
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy	2
Digital variance angiography in patients undergoing lower limb arterial recanalization: cost–effectiveness analysis within the English healthcare setting	2
Assessing the performance of physician's prescribing preference as an instrumental variable in comparative effectiveness research with moderate and small sample sizes: a simulation study	2
Cost–effectiveness analysis of Avance ® allograft for the treatment of peripheral nerve injuries in the USA	2
Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications	2
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus	2
Real-world evidence: a practical toolbox for collecting health state utilities	2
Impact analysis of expanding anti-TNF therapy for Crohn’s disease	2
Trends in adoption of knotless tissue control devices in robotic surgery	2
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study	2
Corrigendum	2
Corrigendum	2
A novel injection device to administer repository corticotropin injection for inflammatory disease treatment: findings from a market research study	2
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy	2
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data	2
The use of nonrandomized evidence to estimate treatment effects in health technology assessment	2
Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain	2
Evaluating the robustness of an AI pathfinder application on eligibility criteria in multiple myeloma trials using real-world data and historical trials	2
Usability evaluation of sufentanil sublingual tablet analgesia in patients following Enhanced Recovery After Surgery	2
Perceptions of indirect treatment comparisons as an evidence base in oncology decision-making: results of an international survey of health technology assessment and payer decision-makers	2
The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting	2